Literature DB >> 2167241

Paf-acether-induced superoxide anion generation in human B cell line.

G Leca1, F Joly, A Vazquez, P Galanaud, E Ninio.   

Abstract

Paf-acether (paf) and lyso phospholipids induced an oxydative burst on EBV-transformed B lymphocyte cell line. Superoxide anion formation measured by lucigenin-dependent chemiluminescence was dependent on both paf concentration and time-course of challenge. Paf C18:0 at 10 microM was more potent than its C16:0 analogue at the same concentration. Choline-containing phospholipids with 2-acyl (long chain) were inactive. The paf antagonists BN 52021 and WEB 2086 structurally unrelated to paf were inactive whereas paf structural analogue CV 3988 inhibited superoxide formation induced by paf and lysophospholipids. Such a phospholipid-induced oxydative burst in B cells might exert an effect in the numerous pathophysiological situations where large amounts of paf are produced by phagocytic cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167241     DOI: 10.1016/0014-5793(90)81146-f

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Voltage-activated proton currents in human lymphocytes.

Authors:  Tom Schilling; Alexander Gratopp; Thomas E DeCoursey; Claudia Eder
Journal:  J Physiol       Date:  2002-11-15       Impact factor: 5.182

2.  Phosphorylation of p47phox is required for receptor-mediated NADPH oxidase/NOX2 activation in Epstein-Barr virus-transformed human B lymphocytes.

Authors:  Sahra Amel Belambri; Margarita Hurtado-Nedelec; Abderrahmane Senator; Karama Makni-Maalej; Michèle Fay; Marie-Anne Gougerot-Pocidalo; Jean-Claude Marie; Pham My-Chan Dang; Jamel El-Benna
Journal:  Am J Blood Res       Date:  2012-10-20

3.  Effect of platelet-activating factor on the growth of human erythroid and myeloid CD34+ progenitors.

Authors:  F Dupuis; N Gachard; A Allegraud; C Dulery; V Praloran; Y Denizot
Journal:  Mediators Inflamm       Date:  1998       Impact factor: 4.711

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.